_id
6919e5173c536f8df23180e7
Ticker
BIOG.LSE
Name
The Biotech Growth Trust PLC
Exchange
LSE
Address
601 Lexington Avenue, New York, NY, United States, 10022
Country
UK
Sector
Financial Services
Industry
Asset Management
Currency
GBX
Website
https://www.biotechgt.com/index.php/biog/home/over
Description
The Biotech Growth Trust PLC is a closed ended equity mutual fund launched by Frostrow Capital LLP. It is co-managed by OrbiMed Capital LLC. The fund invests in public equity markets across the globe. It seeks to invest in stocks of companies operating in the biotechnology sector. The fund invests in stocks of companies across all market capitalizations. It employs fundamental analysis to create its portfolio. The fund benchmarks the performance of its portfolio against the NASDAQ Biotechnology Index. It was previously known as Finsbury Emerging Biotechnology Trust PLC. The Biotech Growth Trust PLC was formed on May 20, 1997 and is domiciled in the United Kingdom.
Last Close
12250000
Volume
9062
Current Price
1180
Change
-0.40816326530612246
Last Updated
2025-12-29T15:03:40.367Z
Image
https://logo.clearbit.com/www.biotechgt.com
Ipo Date
-
Market Cap
257537120
Next Dividend Date
-
Dividend Frequency
-
Dividend Rate
-
Dividend Yield
0
Sentiment
-
Sentiment Sources
0
Rating
3.5
Strong Buy
0
Buy
1
Hold
1
Sell
0
Strong Sell
0
Current Quarter
2025-09-30
Revenue
71197000
Cost Of Revenue
1092000
Gross Profit
-
Operating Expenses
-
Operating Income
69692000
Interest Expense
-
Pretax Income
69426000
Net Income
69421000
Eps
2.7267603199635495
Dividends Per Share
-
Shares Outstanding
21196471
Income Tax Expense
5000
EBITDA
69692000
Operating Margin
97.88614688821158
Total Other Income Expense Net
-266000
Cash
0
Short Term Investments
-
Receivables
8206000
Inventories
-
Total Current Assets
8206000
Property Plant Equipment
-
Total Assets
289974000
Payables
-
Short Term Debt
-
Long Term Debt
-
Total Liabilities
32099000
Equity
257875000
Bs_currency_symbol
GBP
Depreciation
-
Change In Working Capital
63000
Cash From Operations
-2517000
Capital Expenditures
0
Cash From Investing
3364000
Cash From Financing
-9300000
Net Change In Cash
-8453000
Cf_currency_symbol
-
PE
-
PB
116.49751623848765
ROE
26.92040717401842
ROA
23.94042224475298
FCF
-2517000
Fcf Percent
-0.03535261317190331
Piotroski FScore
2
Health Score
66
Deep Value Investing Score
6
Defensive Investing Score
5
Dividend Investing Score
1.5
Economic Moat Investing Score
10
Garp Investing Score
3.5
Growth Investing Score
2
Momentum Investing Score
7.5
Net Net Investing Score
2.5
Quality Investing Score
8.5
Value Investing Score
8
Quarters > 0 > quarter
2025-09-30
Quarters > 0 > income Statement > revenue
71197000
Quarters > 0 > income Statement > cost Of Revenue
1092000
Quarters > 0 > income Statement > gross Profit
-
Quarters > 0 > income Statement > operating Expenses
-
Quarters > 0 > income Statement > operating Income
69692000
Quarters > 0 > income Statement > interest Expense
-
Quarters > 0 > income Statement > pretax Income
69426000
Quarters > 0 > income Statement > net Income
69421000
Quarters > 0 > income Statement > eps
2.7267603199635495
Quarters > 0 > income Statement > dividends Per Share
-
Quarters > 0 > income Statement > shares Outstanding
25459150
Quarters > 0 > income Statement > income Tax Expense
5000
Quarters > 0 > income Statement > EBITDA
69692000
Quarters > 0 > income Statement > operating Margin
97.88614688821158
Quarters > 0 > income Statement > total Other Income Expense Net
-266000
Quarters > 0 > income Statement > currency_symbol
-
Quarters > 0 > balance Sheet > cash
0
Quarters > 0 > balance Sheet > short Term Investments
-
Quarters > 0 > balance Sheet > receivables
8206000
Quarters > 0 > balance Sheet > inventories
-
Quarters > 0 > balance Sheet > total Current Assets
8206000
Quarters > 0 > balance Sheet > property Plant Equipment
-
Quarters > 0 > balance Sheet > total Assets
289974000
Quarters > 0 > balance Sheet > payables
-
Quarters > 0 > balance Sheet > short Term Debt
-
Quarters > 0 > balance Sheet > long Term Debt
-
Quarters > 0 > balance Sheet > total Liabilities
32099000
Quarters > 0 > balance Sheet > equity
257875000
Quarters > 0 > balance Sheet > currency_symbol
GBP
Quarters > 0 > cash Flow > net Income
69421000
Quarters > 0 > cash Flow > depreciation
-
Quarters > 0 > cash Flow > change In Working Capital
63000
Quarters > 0 > cash Flow > cash From Operations
-2517000
Quarters > 0 > cash Flow > capital Expenditures
0
Quarters > 0 > cash Flow > cash From Investing
3364000
Quarters > 0 > cash Flow > cash From Financing
-9300000
Quarters > 0 > cash Flow > net Change In Cash
-8453000
Quarters > 0 > cash Flow > currency_symbol
-
Quarters > 0 > ratios > PE
2.7267603199635495
Quarters > 0 > ratios > PB
116.49751623848765
Quarters > 0 > ratios > ROE
26.92040717401842
Quarters > 0 > ratios > ROA
23.94042224475298
Quarters > 0 > ratios > FCF
-2517000
Quarters > 0 > ratios > Piotroski FScore
2
Quarters > 0 > ratios > fcf Percent
-0.03535261317190331
Quarters > 0 > health Score
66
Quarters > 1 > quarter
2025-03-31
Quarters > 1 > income Statement > revenue
-86369000
Quarters > 1 > income Statement > cost Of Revenue
1225000
Quarters > 1 > income Statement > gross Profit
-
Quarters > 1 > income Statement > operating Expenses
-
Quarters > 1 > income Statement > operating Income
-87991000
Quarters > 1 > income Statement > interest Expense
-
Quarters > 1 > income Statement > pretax Income
-90711000
Quarters > 1 > income Statement > net Income
-90772000
Quarters > 1 > income Statement > eps
-2.869767224230836
Quarters > 1 > income Statement > dividends Per Share
-
Quarters > 1 > income Statement > shares Outstanding
31630440
Quarters > 1 > income Statement > income Tax Expense
61000
Quarters > 1 > income Statement > EBITDA
-87991000
Quarters > 1 > income Statement > operating Margin
101.8779886301798
Quarters > 1 > income Statement > total Other Income Expense Net
-2720000
Quarters > 1 > income Statement > currency_symbol
-
Quarters > 1 > balance Sheet > cash
8453000
Quarters > 1 > balance Sheet > short Term Investments
-
Quarters > 1 > balance Sheet > receivables
-
Quarters > 1 > balance Sheet > inventories
-
Quarters > 1 > balance Sheet > total Current Assets
8470000
Quarters > 1 > balance Sheet > property Plant Equipment
-
Quarters > 1 > balance Sheet > total Assets
226629000
Quarters > 1 > balance Sheet > payables
405000
Quarters > 1 > balance Sheet > short Term Debt
-
Quarters > 1 > balance Sheet > long Term Debt
-
Quarters > 1 > balance Sheet > total Liabilities
5423000
Quarters > 1 > balance Sheet > equity
221206000
Quarters > 1 > balance Sheet > currency_symbol
GBP
Quarters > 1 > cash Flow > net Income
-90772000
Quarters > 1 > cash Flow > depreciation
-
Quarters > 1 > cash Flow > change In Working Capital
-263000
Quarters > 1 > cash Flow > cash From Operations
-2980000
Quarters > 1 > cash Flow > capital Expenditures
0
Quarters > 1 > cash Flow > cash From Investing
87002000
Quarters > 1 > cash Flow > cash From Financing
-79390000
Quarters > 1 > cash Flow > net Change In Cash
4485000
Quarters > 1 > cash Flow > currency_symbol
-
Quarters > 1 > ratios > PE
-2.869767224230836
Quarters > 1 > ratios > PB
168.72923519253547
Quarters > 1 > ratios > ROE
-41.035053298735114
Quarters > 1 > ratios > ROA
-40.05312647542901
Quarters > 1 > ratios > FCF
-2980000
Quarters > 1 > ratios > Piotroski FScore
1
Quarters > 1 > ratios > fcf Percent
0.03450312033252672
Quarters > 1 > health Score
28
Quarters > 2 > quarter
2024-09-30
Quarters > 2 > income Statement > revenue
10390000
Quarters > 2 > income Statement > cost Of Revenue
-
Quarters > 2 > income Statement > gross Profit
10390000
Quarters > 2 > income Statement > operating Expenses
2037000
Quarters > 2 > income Statement > operating Income
8353000
Quarters > 2 > income Statement > interest Expense
-
Quarters > 2 > income Statement > pretax Income
8195000
Quarters > 2 > income Statement > net Income
8111000
Quarters > 2 > income Statement > eps
0.24678378597362016
Quarters > 2 > income Statement > dividends Per Share
-
Quarters > 2 > income Statement > shares Outstanding
32866827
Quarters > 2 > income Statement > income Tax Expense
84000
Quarters > 2 > income Statement > EBITDA
8353000
Quarters > 2 > income Statement > operating Margin
80.39461020211742
Quarters > 2 > income Statement > total Other Income Expense Net
-158000
Quarters > 2 > income Statement > currency_symbol
-
Quarters > 2 > balance Sheet > cash
3968000
Quarters > 2 > balance Sheet > short Term Investments
-
Quarters > 2 > balance Sheet > receivables
26967000
Quarters > 2 > balance Sheet > inventories
-
Quarters > 2 > balance Sheet > total Current Assets
30935000
Quarters > 2 > balance Sheet > property Plant Equipment
-
Quarters > 2 > balance Sheet > total Assets
406442000
Quarters > 2 > balance Sheet > payables
-
Quarters > 2 > balance Sheet > short Term Debt
39024000
Quarters > 2 > balance Sheet > long Term Debt
-
Quarters > 2 > balance Sheet > total Liabilities
52326000
Quarters > 2 > balance Sheet > equity
354116000
Quarters > 2 > balance Sheet > currency_symbol
GBP
Quarters > 2 > cash Flow > net Income
8111000
Quarters > 2 > cash Flow > depreciation
-8353000
Quarters > 2 > cash Flow > change In Working Capital
-74000
Quarters > 2 > cash Flow > cash From Operations
-2702000
Quarters > 2 > cash Flow > capital Expenditures
0
Quarters > 2 > cash Flow > cash From Investing
28846000
Quarters > 2 > cash Flow > cash From Financing
-24307000
Quarters > 2 > cash Flow > net Change In Cash
1837000
Quarters > 2 > cash Flow > currency_symbol
-
Quarters > 2 > ratios > PE
0.24678378597362016
Quarters > 2 > ratios > PB
109.52020202419546
Quarters > 2 > ratios > ROE
2.290492381027686
Quarters > 2 > ratios > ROA
1.9956106898401247
Quarters > 2 > ratios > FCF
-2702000
Quarters > 2 > ratios > Piotroski FScore
2
Quarters > 2 > ratios > fcf Percent
-0.26005774783445623
Quarters > 2 > health Score
45
Quarters > 3 > quarter
2024-03-31
Quarters > 3 > income Statement > revenue
90778000
Quarters > 3 > income Statement > cost Of Revenue
3228000
Quarters > 3 > income Statement > gross Profit
87550000
Quarters > 3 > income Statement > operating Expenses
2035000
Quarters > 3 > income Statement > operating Income
88743000
Quarters > 3 > income Statement > interest Expense
-
Quarters > 3 > income Statement > pretax Income
88412000
Quarters > 3 > income Statement > net Income
88336000
Quarters > 3 > income Statement > eps
2.4369956105884283
Quarters > 3 > income Statement > dividends Per Share
-
Quarters > 3 > income Statement > shares Outstanding
36247911
Quarters > 3 > income Statement > income Tax Expense
76000
Quarters > 3 > income Statement > EBITDA
-165500
Quarters > 3 > income Statement > operating Margin
97.75826742162198
Quarters > 3 > income Statement > total Other Income Expense Net
-331000
Quarters > 3 > income Statement > currency_symbol
-
Quarters > 3 > balance Sheet > cash
2131000
Quarters > 3 > balance Sheet > short Term Investments
-
Quarters > 3 > balance Sheet > receivables
14508000
Quarters > 3 > balance Sheet > inventories
0
Quarters > 3 > balance Sheet > total Current Assets
16666000
Quarters > 3 > balance Sheet > property Plant Equipment
-
Quarters > 3 > balance Sheet > total Assets
411420000
Quarters > 3 > balance Sheet > payables
167000
Quarters > 3 > balance Sheet > short Term Debt
47078000
Quarters > 3 > balance Sheet > long Term Debt
-
Quarters > 3 > balance Sheet > total Liabilities
50113000
Quarters > 3 > balance Sheet > equity
361307000
Quarters > 3 > balance Sheet > currency_symbol
GBP
Quarters > 3 > cash Flow > net Income
88336000
Quarters > 3 > cash Flow > depreciation
-88743000
Quarters > 3 > cash Flow > change In Working Capital
-15000
Quarters > 3 > cash Flow > cash From Operations
-2369000
Quarters > 3 > cash Flow > capital Expenditures
0
Quarters > 3 > cash Flow > cash From Investing
-13698000
Quarters > 3 > cash Flow > cash From Financing
15065000
Quarters > 3 > cash Flow > net Change In Cash
-1002000
Quarters > 3 > cash Flow > currency_symbol
-
Quarters > 3 > ratios > PE
2.4369956105884283
Quarters > 3 > ratios > PB
118.38280182780849
Quarters > 3 > ratios > ROE
24.449014273180424
Quarters > 3 > ratios > ROA
21.471002868115306
Quarters > 3 > ratios > FCF
-2369000
Quarters > 3 > ratios > Piotroski FScore
2
Quarters > 3 > ratios > fcf Percent
-0.026096631342395735
Quarters > 3 > health Score
66
Annuals > 0 > quarter
2025-03-31
Annuals > 0 > income Statement > revenue
-77484000
Annuals > 0 > income Statement > cost Of Revenue
1325000
Annuals > 0 > income Statement > gross Profit
-78809000
Annuals > 0 > income Statement > operating Expenses
3707000
Annuals > 0 > income Statement > operating Income
-82516000
Annuals > 0 > income Statement > interest Expense
1325000
Annuals > 0 > income Statement > pretax Income
-82516000
Annuals > 0 > income Statement > net Income
-82661000
Annuals > 0 > income Statement > eps
-2.622983383794849
Annuals > 0 > income Statement > dividends Per Share
0
Annuals > 0 > income Statement > shares Outstanding
31514115
Annuals > 0 > income Statement > income Tax Expense
145000
Annuals > 0 > income Statement > EBITDA
-82516000
Annuals > 0 > income Statement > operating Margin
106.49424397294925
Annuals > 0 > income Statement > total Other Income Expense Net
-
Annuals > 0 > income Statement > currency_symbol
GBP
Annuals > 0 > balance Sheet > cash
8453000
Annuals > 0 > balance Sheet > short Term Investments
-
Annuals > 0 > balance Sheet > receivables
-
Annuals > 0 > balance Sheet > inventories
-
Annuals > 0 > balance Sheet > total Current Assets
8470000
Annuals > 0 > balance Sheet > property Plant Equipment
-
Annuals > 0 > balance Sheet > total Assets
226629000
Annuals > 0 > balance Sheet > payables
405000
Annuals > 0 > balance Sheet > short Term Debt
-
Annuals > 0 > balance Sheet > long Term Debt
-
Annuals > 0 > balance Sheet > total Liabilities
5423000
Annuals > 0 > balance Sheet > equity
221206000
Annuals > 0 > balance Sheet > currency_symbol
GBP
Annuals > 0 > cash Flow > net Income
-82516000
Annuals > 0 > cash Flow > depreciation
-
Annuals > 0 > cash Flow > change In Working Capital
-337000
Annuals > 0 > cash Flow > cash From Operations
-5087000
Annuals > 0 > cash Flow > capital Expenditures
0
Annuals > 0 > cash Flow > cash From Investing
115848000
Annuals > 0 > cash Flow > cash From Financing
-104292000
Annuals > 0 > cash Flow > net Change In Cash
6322000
Annuals > 0 > cash Flow > currency_symbol
GBP
Annuals > 0 > ratios > PE
-2.622983383794849
Annuals > 0 > ratios > PB
174.17601163449453
Annuals > 0 > ratios > ROE
-37.36833539777402
Annuals > 0 > ratios > ROA
-36.47414938070591
Annuals > 0 > ratios > FCF
-5087000
Annuals > 0 > ratios > Piotroski FScore
0
Annuals > 0 > ratios > fcf Percent
0.06565226369314955
Annuals > 0 > health Score
30
Annuals > 1 > quarter
2024-03-31
Annuals > 1 > income Statement > revenue
80346000
Annuals > 1 > income Statement > cost Of Revenue
2347000
Annuals > 1 > income Statement > gross Profit
77999000
Annuals > 1 > income Statement > operating Expenses
3240000
Annuals > 1 > income Statement > operating Income
76495000
Annuals > 1 > income Statement > interest Expense
1115000
Annuals > 1 > income Statement > pretax Income
74759000
Annuals > 1 > income Statement > net Income
74600000
Annuals > 1 > income Statement > eps
2.069836390809083
Annuals > 1 > income Statement > dividends Per Share
0
Annuals > 1 > income Statement > shares Outstanding
36041496
Annuals > 1 > income Statement > income Tax Expense
159000
Annuals > 1 > income Statement > EBITDA
74759000
Annuals > 1 > income Statement > operating Margin
95.20697981231176
Annuals > 1 > income Statement > total Other Income Expense Net
-1736000
Annuals > 1 > income Statement > currency_symbol
GBP
Annuals > 1 > balance Sheet > cash
2131000
Annuals > 1 > balance Sheet > short Term Investments
-
Annuals > 1 > balance Sheet > receivables
14508000
Annuals > 1 > balance Sheet > inventories
0
Annuals > 1 > balance Sheet > total Current Assets
16666000
Annuals > 1 > balance Sheet > property Plant Equipment
-
Annuals > 1 > balance Sheet > total Assets
411420000
Annuals > 1 > balance Sheet > payables
167000
Annuals > 1 > balance Sheet > short Term Debt
47078000
Annuals > 1 > balance Sheet > long Term Debt
-
Annuals > 1 > balance Sheet > total Liabilities
50113000
Annuals > 1 > balance Sheet > equity
361307000
Annuals > 1 > balance Sheet > currency_symbol
GBP
Annuals > 1 > cash Flow > net Income
74600000
Annuals > 1 > cash Flow > depreciation
-76495000
Annuals > 1 > cash Flow > change In Working Capital
92000
Annuals > 1 > cash Flow > cash From Operations
-4241000
Annuals > 1 > cash Flow > capital Expenditures
0
Annuals > 1 > cash Flow > cash From Investing
22341000
Annuals > 1 > cash Flow > cash From Financing
-18741000
Annuals > 1 > cash Flow > net Change In Cash
-641000
Annuals > 1 > cash Flow > currency_symbol
GBP
Annuals > 1 > ratios > PE
2.069836390809083
Annuals > 1 > ratios > PB
121.95695215328792
Annuals > 1 > ratios > ROE
20.647261193389554
Annuals > 1 > ratios > ROA
18.13232220115697
Annuals > 1 > ratios > FCF
-4241000
Annuals > 1 > ratios > Piotroski FScore
2
Annuals > 1 > ratios > fcf Percent
-0.052784208299106364
Annuals > 1 > health Score
66
Annuals > 2 > quarter
2023-03-31
Annuals > 2 > income Statement > revenue
-37654000
Annuals > 2 > income Statement > cost Of Revenue
5313000
Annuals > 2 > income Statement > gross Profit
-42967000
Annuals > 2 > income Statement > operating Expenses
3588000
Annuals > 2 > income Statement > operating Income
-36691000
Annuals > 2 > income Statement > interest Expense
792000
Annuals > 2 > income Statement > pretax Income
-41242000
Annuals > 2 > income Statement > net Income
-41298000
Annuals > 2 > income Statement > eps
-1.0250765220691047
Annuals > 2 > income Statement > dividends Per Share
0
Annuals > 2 > income Statement > shares Outstanding
40287724
Annuals > 2 > income Statement > income Tax Expense
56000
Annuals > 2 > income Statement > EBITDA
-5343000
Annuals > 2 > income Statement > operating Margin
97.44250278854835
Annuals > 2 > income Statement > total Other Income Expense Net
-4551000
Annuals > 2 > income Statement > currency_symbol
GBP
Annuals > 2 > balance Sheet > cash
2772000
Annuals > 2 > balance Sheet > short Term Investments
-
Annuals > 2 > balance Sheet > receivables
487000
Annuals > 2 > balance Sheet > inventories
-
Annuals > 2 > balance Sheet > total Current Assets
3280000
Annuals > 2 > balance Sheet > property Plant Equipment
-
Annuals > 2 > balance Sheet > total Assets
360509000
Annuals > 2 > balance Sheet > payables
6206000
Annuals > 2 > balance Sheet > short Term Debt
20170000
Annuals > 2 > balance Sheet > long Term Debt
-
Annuals > 2 > balance Sheet > total Liabilities
30218000
Annuals > 2 > balance Sheet > equity
330291000
Annuals > 2 > balance Sheet > currency_symbol
GBP
Annuals > 2 > cash Flow > net Income
-41242000
Annuals > 2 > cash Flow > depreciation
36691000
Annuals > 2 > cash Flow > change In Working Capital
-88000
Annuals > 2 > cash Flow > cash From Operations
-5890000
Annuals > 2 > cash Flow > capital Expenditures
0
Annuals > 2 > cash Flow > cash From Investing
45694000
Annuals > 2 > cash Flow > cash From Financing
-37032000
Annuals > 2 > cash Flow > net Change In Cash
2772000
Annuals > 2 > cash Flow > currency_symbol
GBP
Annuals > 2 > ratios > PE
-1.0250765220691047
Annuals > 2 > ratios > PB
149.12694535943152
Annuals > 2 > ratios > ROE
-12.503519623604639
Annuals > 2 > ratios > ROA
-11.455469905050913
Annuals > 2 > ratios > FCF
-5890000
Annuals > 2 > ratios > Piotroski FScore
1
Annuals > 2 > ratios > fcf Percent
0.15642428427258726
Annuals > 2 > health Score
40
Annuals > 3 > quarter
2022-03-31
Annuals > 3 > income Statement > revenue
-209711000
Annuals > 3 > income Statement > cost Of Revenue
4802000
Annuals > 3 > income Statement > gross Profit
-214513000
Annuals > 3 > income Statement > operating Expenses
-7441000
Annuals > 3 > income Statement > operating Income
-199755000
Annuals > 3 > income Statement > interest Expense
175000
Annuals > 3 > income Statement > pretax Income
-202270000
Annuals > 3 > income Statement > net Income
-202419000
Annuals > 3 > income Statement > eps
-4.8844433258682045
Annuals > 3 > income Statement > dividends Per Share
0
Annuals > 3 > income Statement > shares Outstanding
41441570
Annuals > 3 > income Statement > income Tax Expense
149000
Annuals > 3 > income Statement > EBITDA
-10729000
Annuals > 3 > income Statement > operating Margin
95.2525141742684
Annuals > 3 > income Statement > total Other Income Expense Net
7871000
Annuals > 3 > income Statement > currency_symbol
GBP
Annuals > 3 > balance Sheet > cash
1502000
Annuals > 3 > balance Sheet > short Term Investments
-
Annuals > 3 > balance Sheet > receivables
4725000
Annuals > 3 > balance Sheet > inventories
-
Annuals > 3 > balance Sheet > total Current Assets
49000
Annuals > 3 > balance Sheet > property Plant Equipment
-
Annuals > 3 > balance Sheet > total Assets
427448000
Annuals > 3 > balance Sheet > payables
452000
Annuals > 3 > balance Sheet > short Term Debt
31741000
Annuals > 3 > balance Sheet > long Term Debt
-
Annuals > 3 > balance Sheet > total Liabilities
33240000
Annuals > 3 > balance Sheet > equity
394208000
Annuals > 3 > balance Sheet > currency_symbol
GBP
Annuals > 3 > cash Flow > net Income
-202270000
Annuals > 3 > cash Flow > depreciation
199755000
Annuals > 3 > cash Flow > change In Working Capital
-18269000
Annuals > 3 > cash Flow > cash From Operations
-12141000
Annuals > 3 > cash Flow > capital Expenditures
1045000
Annuals > 3 > cash Flow > cash From Investing
13032000
Annuals > 3 > cash Flow > cash From Financing
-2393000
Annuals > 3 > cash Flow > net Change In Cash
-1502000
Annuals > 3 > cash Flow > currency_symbol
GBP
Annuals > 3 > ratios > PE
-4.8844433258682045
Annuals > 3 > ratios > PB
128.52597152559053
Annuals > 3 > ratios > ROE
-51.34827299293774
Annuals > 3 > ratios > ROA
-47.35523385300668
Annuals > 3 > ratios > FCF
-13186000
Annuals > 3 > ratios > Piotroski FScore
0
Annuals > 3 > ratios > fcf Percent
0.06287700692858267
Annuals > 3 > health Score
30
Valuation > metrics > PE
2.7267603199635495
Valuation > metrics > PB
116.49751623848765
Valuation > final Score
40
Valuation > verdict
1855.3% Overvalued
Profitability > metrics > ROE
26.92040717401842
Profitability > metrics > ROA
845.9785522788204
Profitability > metrics > Net Margin
0.975055128727334
Profitability > final Score
100
Profitability > verdict
Adequate
Risk > metrics > Debt Equity
0.12447503635482307
Risk > metrics > Interest Coverage
262
Risk > final Score
100
Risk > verdict
Low
Liquidity > final Score
50
Liquidity > verdict
Weak
Prev Valuations > 0
20
Prev Valuations > 1
40
Prev Valuations > 2
40
Prev Profitabilities > 0
30
Prev Profitabilities > 1
65
Prev Profitabilities > 2
100
Prev Risks > 0
-69
Prev Risks > 1
100
Prev Risks > 2
64
Prev Liquidities > 0
100
Prev Liquidities > 1
50
Prev Liquidities > 2
28
Updated At
2026-01-20T23:00:08.921Z
Earnings History > 0 > period
2025-09-30
Earnings History > 0 > report Date
2025-11-25
Earnings History > 0 > date
2025-09-30
Earnings History > 0 > before After Market
BeforeMarket
Earnings History > 0 > currency
-
Earnings History > 0 > eps Actual
2.73
Earnings History > 0 > eps Estimate
-
Earnings History > 0 > eps Difference
0
Earnings History > 0 > surprise Percent
-
Earnings History > 1 > period
2025-03-31
Earnings History > 1 > report Date
2025-06-04
Earnings History > 1 > date
2025-03-31
Earnings History > 1 > before After Market
BeforeMarket
Earnings History > 1 > currency
-
Earnings History > 1 > eps Actual
-3.01
Earnings History > 1 > eps Estimate
-
Earnings History > 1 > eps Difference
0
Earnings History > 1 > surprise Percent
-
Earnings History > 2 > period
2024-09-30
Earnings History > 2 > report Date
2024-11-27
Earnings History > 2 > date
2024-09-30
Earnings History > 2 > before After Market
-
Earnings History > 2 > currency
-
Earnings History > 2 > eps Actual
0.25
Earnings History > 2 > eps Estimate
0
Earnings History > 2 > eps Difference
0.25
Earnings History > 2 > surprise Percent
-
Earnings History > 3 > period
2022-09-30
Earnings History > 3 > report Date
2022-11-16
Earnings History > 3 > date
2022-09-30
Earnings History > 3 > before After Market
-
Earnings History > 3 > currency
-
Earnings History > 3 > eps Actual
0.91
Earnings History > 3 > eps Estimate
0
Earnings History > 3 > eps Difference
0.91
Earnings History > 3 > surprise Percent
-
Earnings History > 4 > period
2022-03-31
Earnings History > 4 > report Date
2022-06-01
Earnings History > 4 > date
2022-03-31
Earnings History > 4 > before After Market
-
Earnings History > 4 > currency
-
Earnings History > 4 > eps Actual
-3.7
Earnings History > 4 > eps Estimate
0
Earnings History > 4 > eps Difference
-3.7
Earnings History > 4 > surprise Percent
-
Earnings History > 5 > period
2021-09-30
Earnings History > 5 > report Date
2021-11-11
Earnings History > 5 > date
2021-09-30
Earnings History > 5 > before After Market
-
Earnings History > 5 > currency
-
Earnings History > 5 > eps Actual
-1.2
Earnings History > 5 > eps Estimate
0
Earnings History > 5 > eps Difference
-1.2
Earnings History > 5 > surprise Percent
-
Earnings History > 6 > period
2021-03-31
Earnings History > 6 > report Date
2021-06-04
Earnings History > 6 > date
2021-03-31
Earnings History > 6 > before After Market
-
Earnings History > 6 > currency
-
Earnings History > 6 > eps Actual
0.55
Earnings History > 6 > eps Estimate
0
Earnings History > 6 > eps Difference
0.55
Earnings History > 6 > surprise Percent
-
Earnings History > 7 > period
2020-09-30
Earnings History > 7 > report Date
2020-11-16
Earnings History > 7 > date
2020-09-30
Earnings History > 7 > before After Market
-
Earnings History > 7 > currency
-
Earnings History > 7 > eps Actual
4.53
Earnings History > 7 > eps Estimate
0
Earnings History > 7 > eps Difference
4.53
Earnings History > 7 > surprise Percent
-
Earnings History > 8 > period
2020-03-31
Earnings History > 8 > report Date
2020-06-03
Earnings History > 8 > date
2020-03-31
Earnings History > 8 > before After Market
-
Earnings History > 8 > currency
-
Earnings History > 8 > eps Actual
1.97
Earnings History > 8 > eps Estimate
0
Earnings History > 8 > eps Difference
1.97
Earnings History > 8 > surprise Percent
-
Earnings History > 9 > period
2019-09-30
Earnings History > 9 > report Date
2019-11-12
Earnings History > 9 > date
2019-09-30
Earnings History > 9 > before After Market
-
Earnings History > 9 > currency
-
Earnings History > 9 > eps Actual
-0.47
Earnings History > 9 > eps Estimate
0
Earnings History > 9 > eps Difference
-0.47
Earnings History > 9 > surprise Percent
-
Earnings History > 10 > period
2019-03-31
Earnings History > 10 > report Date
2019-05-24
Earnings History > 10 > date
2019-03-31
Earnings History > 10 > before After Market
-
Earnings History > 10 > currency
-
Earnings History > 10 > eps Actual
-1.14
Earnings History > 10 > eps Estimate
0
Earnings History > 10 > eps Difference
-1.14
Earnings History > 10 > surprise Percent
-
Earnings History > 11 > period
2018-09-30
Earnings History > 11 > report Date
2018-11-09
Earnings History > 11 > date
2018-09-30
Earnings History > 11 > before After Market
-
Earnings History > 11 > currency
-
Earnings History > 11 > eps Actual
1.47
Earnings History > 11 > eps Estimate
0
Earnings History > 11 > eps Difference
1.47
Earnings History > 11 > surprise Percent
-
Earnings History > 12 > period
2018-03-31
Earnings History > 12 > report Date
2018-06-08
Earnings History > 12 > date
2018-03-31
Earnings History > 12 > before After Market
-
Earnings History > 12 > currency
-
Earnings History > 12 > eps Actual
-1.4
Earnings History > 12 > eps Estimate
0
Earnings History > 12 > eps Difference
-1.4
Earnings History > 12 > surprise Percent
-
Earnings History > 13 > period
2017-09-30
Earnings History > 13 > report Date
2017-11-09
Earnings History > 13 > date
2017-09-30
Earnings History > 13 > before After Market
-
Earnings History > 13 > currency
-
Earnings History > 13 > eps Actual
0.87
Earnings History > 13 > eps Estimate
0
Earnings History > 13 > eps Difference
0.87
Earnings History > 13 > surprise Percent
-
Earnings History > 14 > period
2017-03-31
Earnings History > 14 > report Date
2017-06-07
Earnings History > 14 > date
2017-03-31
Earnings History > 14 > before After Market
-
Earnings History > 14 > currency
-
Earnings History > 14 > eps Actual
0.43
Earnings History > 14 > eps Estimate
0
Earnings History > 14 > eps Difference
0.43
Earnings History > 14 > surprise Percent
-
Earnings History > 15 > period
2016-09-30
Earnings History > 15 > report Date
2016-11-07
Earnings History > 15 > date
2016-09-30
Earnings History > 15 > before After Market
-
Earnings History > 15 > currency
-
Earnings History > 15 > eps Actual
1.27
Earnings History > 15 > eps Estimate
0
Earnings History > 15 > eps Difference
1.27
Earnings History > 15 > surprise Percent
-
Earnings History > 16 > period
2016-03-31
Earnings History > 16 > report Date
2016-06-06
Earnings History > 16 > date
2016-03-31
Earnings History > 16 > before After Market
-
Earnings History > 16 > currency
-
Earnings History > 16 > eps Actual
-0.51
Earnings History > 16 > eps Estimate
0
Earnings History > 16 > eps Difference
-0.51
Earnings History > 16 > surprise Percent
-
The Biotech Growth Trust PLC is a closed ended equity mutual fund launched by Frostrow Capital LLP. It is co-managed by OrbiMed Capital LLC. The fund invests in public equity markets across the globe. It seeks to invest in stocks of companies operating in the biotechnology sector. The fund invests in stocks of companies across all market capitalizations. It employs fundamental analysis to create its portfolio. The fund benchmarks the performance of its portfolio against the NASDAQ Biotechnology Index. It was previously known as Finsbury Emerging Biotechnology Trust PLC. The Biotech Growth Trust PLC was formed on May 20, 1997 and is domiciled in the United Kingdom.
Stock Price
GBp 0.00
decrease compared to yesterday.
Dividend
Frequency:
Rate:
N/ANext Payout:
N/AThe London Stock Exchange’s Discussion Paper on the Future of AIM akingump.com
Read more →Showing 2 of 10
(Last Updated 2025-09-30)
Rating:
BUY
$
Analyst Picks
Strong Buy
0
Buy
1
Hold
1
Sell
0
Strong Sell
0
(Last Updated 2025-09-30)
Health Score
Price to Book Ratio (P/B)
-
Very High
Low ≤ 1
High ≥ 3
Return on Equity (ROE)
-
Very High
Low ≤ 5%
High ≥ 25%
Return on Assets (ROA)
-
Very High
Low ≤ 2%
High ≥ 10%
Free Cash Flow - Revenue % (FCF)
-
Very Low
Low ≤ 5%
High ≥ 15%
Debt to Equity
-
Very High
Low ≥ 1
High ≤ 0.3
* Institutions hold a combined 0.00% of the total shares of The Biotech Growth Trust PLC
* Investors data is estimated based on stocks listed on Finnton that are currently held by Institution/Fund.
Date
—
EPS Estimate
—
Date
2025-09-30
EPS Actual
2.73
EPS Estimate
—
EPS Difference
0
Surprise Percent
0%
(Last Updated 2025-09-30)
(Last Updated 2025-09-30)
Revenue
£ 0
Cost Of Revenue
£ 0
Gross Profit
£ 0
Operating Expenses
£ 0
Operating Income
£ 0
Interest Expense
£ 0
Pretax Income
£ 0
Net Income
£ 0
Income Tax Expense
£ 0
EBITDA
£ 0
Total Other Income Expense Net
£ 0
Earnings Per Share
0
Dividends Per Share
0
Shares Outstanding
0
Operating Margin
0%
(Last Updated 2025-09-30)
Cash
£ 0
Short Term Investments
£ 0
Receivables
£ 0
Inventories
£ 0
Total Current Assets
£ 0
Property Plant Equipment
£ 0
Total Assets
£ 0
Payables
£ 0
Short Term Debt
£ 0
Long Term Debt
£ 0
Total Liabilities
£ 0
Equity
£ 0
(Last Updated 2025-09-30)
Net Income
£ 0
Depreciation
£ 0
Change In Working Capital
£ 0
Cash From Operations
£ 0
Capital Expenditures
£ 0
Cash From Investing
£ 0
Cash From Financing
£ 0
Net Change In Cash
£ 0
Disclaimer: Finnton is a stock screener tool provided for informational and educational purposes only. The data, analysis, and insights offered on this website do not constitute financial, investment, tax, or legal advice. Users are solely responsible for their own investment decisions, and Finnton makes no guarantees regarding the accuracy, completeness, or reliability of the information provided. Past performance is not indicative of future results. Always conduct your own research and consult with a licensed financial advisor before making any investment decisions.